These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 12520735

  • 1. [Bcl-2 antisense oligodeoxynucleotide enhances araninosyl cytosine-induced apoptosis of primary leukemia cells].
    Lei XY, Zhang H, He DM.
    Ai Zheng; 2002 Dec; 21(12):1301-4. PubMed ID: 12520735
    [Abstract] [Full Text] [Related]

  • 2. [Design of antisense oligodeoxynucleotide targeting at bcl-2 mRNA and observation on its effect on the sensitivity of leukemia cells to arabinosyl cytosine].
    Lei XY, Zhang Y.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):41-4. PubMed ID: 12667288
    [Abstract] [Full Text] [Related]

  • 3. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S, Bullock G, Nuñez G, Tang C, Ibrado AM, Huang Y, Bhalla K.
    Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
    [Abstract] [Full Text] [Related]

  • 4. [A novel bcl-2 antisense oligodeoxynucleotide F951 increases sensitivity of HL-60 cells to Ara-C].
    Li DL, Lu LH, Chen YY, Lin ZX.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):752-6. PubMed ID: 15631654
    [Abstract] [Full Text] [Related]

  • 5. [Apoptosis of human gastric cancer cells induced by bcl-2 antisense oligodeoxynucleotides].
    Lu P, Chen J.
    Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):253-5. PubMed ID: 11776807
    [Abstract] [Full Text] [Related]

  • 6. Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN.
    Jahrsdörfer B, Jox R, Mühlenhoff L, Tschoep K, Krug A, Rothenfusser S, Meinhardt G, Emmerich B, Endres S, Hartmann G.
    J Leukoc Biol; 2002 Jul; 72(1):83-92. PubMed ID: 12101266
    [Abstract] [Full Text] [Related]

  • 7. Chemosensitization of breast carcinoma cells with the use of bcl-2 antisense oligodeoxynucleotide.
    Yang JH, Feng F, Qian H, Cheng H.
    Breast; 2004 Jun; 13(3):227-31. PubMed ID: 15177426
    [Abstract] [Full Text] [Related]

  • 8. [Bcl-2 antisense oligodeoxyribonucleotide increases apoptosis of lung carcinoma cells induced by cisplatin].
    Ouyang N, Ran P, Qiu Z.
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Dec; 23(12):722-4. PubMed ID: 11778475
    [Abstract] [Full Text] [Related]

  • 9. [New insight into the mechanism of p53 inducing leukemia cell apoptosis].
    Chen YZ, Wu Y, Liang M, Li NN, Zhang ZX, Lu LH.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Dec; 24(12):640-3. PubMed ID: 14761612
    [Abstract] [Full Text] [Related]

  • 10. [Ara-c induced apoptosis in human myeloid leukemia cell line HL-60].
    Zhou J, Chen Y, Li C.
    Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):107-10. PubMed ID: 10743072
    [Abstract] [Full Text] [Related]

  • 11. The combination regimen of idarubicin and taxotere is effective against human drug-resistant leukemic cell lines.
    Majlessipour F, Avramis IA, Kwock R, Weinberg KI, Avrami VI.
    Anticancer Res; 2002 Mar; 22(3):1361-8. PubMed ID: 12168812
    [Abstract] [Full Text] [Related]

  • 12. Anti-Fas IgM monoclonal antibody enhances apoptosis induced by low-dose cytosine arabinoside.
    Nakamura S, Takeshima M, Nakamura Y, Ohtake S, Matsuda T.
    Anticancer Res; 1999 Mar; 19(1A):197-204. PubMed ID: 10226543
    [Abstract] [Full Text] [Related]

  • 13. Co-transfection of MRP and bcl-2 antisense S-oligodeoxynucleotides reduces drug resistance in cisplatin-resistant lung cancer cells.
    Wang J, Liu X, Jiang W.
    Chin Med J (Engl); 2000 Oct; 113(10):957-60. PubMed ID: 11775848
    [Abstract] [Full Text] [Related]

  • 14. [Apoptosis increased by bcl-2 antisense ODN in MCF-7 cell line].
    Zheng J, Yao Z.
    Zhonghua Wai Ke Za Zhi; 1999 Jul; 37(7):418-20. PubMed ID: 11829877
    [Abstract] [Full Text] [Related]

  • 15. Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein.
    Bullock G, Ray S, Reed JC, Krajewski S, Ibrado AM, Huang Y, Bhalla K.
    Leukemia; 1996 Nov; 10(11):1731-40. PubMed ID: 8892676
    [Abstract] [Full Text] [Related]

  • 16. All- trans-retinoic acid increases cytotoxicity of 1-beta-D-arabinofuranosylcytosine in NB4 cells.
    Flanagan SA, Meckling KA.
    Cancer Chemother Pharmacol; 2003 May; 51(5):363-75. PubMed ID: 12736759
    [Abstract] [Full Text] [Related]

  • 17. RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines.
    Cioca DP, Aoki Y, Kiyosawa K.
    Cancer Gene Ther; 2003 Feb; 10(2):125-33. PubMed ID: 12536201
    [Abstract] [Full Text] [Related]

  • 18. [The toxic effects of high-dose Bcl-2 antisense phosphorothioate oligodeoxynucleotides incubation on cell line].
    Lin Y, Lü L, Chen Z.
    Zhonghua Yi Xue Za Zhi; 2000 Sep; 80(9):694-7. PubMed ID: 11798838
    [Abstract] [Full Text] [Related]

  • 19. [Apoptosis and regulation of expressions of apoptosis-related gene Bcl-2 and p53 induced by selenium dioxide in three leukemia cell lines].
    Wang XH, Wei YM, Bai H, Ou JF, Lu JH, Zheng RL.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1160-3. PubMed ID: 15485790
    [Abstract] [Full Text] [Related]

  • 20. Modulation of the expression of Bcl-2 and related proteins in human leukemia cells by protein kinase C activators: relationship to effects on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis.
    Bartimole TM, Vrana JA, Freemerman AJ, Jarvis WD, Reed JC, Boise LH, Grant S.
    Cell Death Differ; 1997 May; 4(4):294-303. PubMed ID: 16465244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.